A report from Piper Jaffray reiterates its Neutral rating and $69 price target on Johnson & Johnson JNJ.
The report states, “We came away from our session with management with a better understanding of Ethicon's strategic approach to its core businesses. Management emphasized the company's focus on driving innovation and geographic expansion, especially in the BRIC markets, to help offset sluggish growth trends and pricing pressure in developed markets.”
JNJ closed yesterday at $64.72.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in